(Total Views: 1298)
Posted On: 04/12/2019 11:35:40 AM
Post# of 93

$OPK News Article - OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial https://marketwirenews.com/news-releases/opko...90554.html


My Twitter: WhyteStocks